Pancreatic Cancer Research

Clinical trialObservationalUnknown

Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer

The Causes of Heterotopic Ossification in Abdominal Incision After Pancreatic Surgery:A Single-center Prospective Study

Outcome
Outcome unknown
Phase
Observational
Status
Unknown
Study type
Observational
Start
1 September 2019
Listed end
31 December 2025
Enrollment
105 participants
Sites
1
Primary outcomes
Incidence of HOAI; Bone alkaline phosphatase
Sponsor type
Academic / other
Results posted
No
Last update
8 August 2019

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

To investigate whether pancreatic cancer is the cause of heterotopic ossification of abdominal incision.

Detailed description public domain (ClinicalTrials.gov)

Heterotopic ossification of abdominal incision (HOAI) has long been regarded as a rare complication after general surgery. However,according to our retrospective analysis. HOAI was more frequently observed in the malignancy group (33/121 cases, 27.3%) than in the non- malignancy group. Because of the many biases in the retrospective analysis, the result was not widely shared. The purpose of this prospective study is to confirm that pancreatic cancer is the cause of heterotopic ossification of abdominal incisions. According to postoperative pathology, the patients were divided into two groups: pancreatic cancer group and benign diseases group.The researchers will observe whether patients develop heterotopic ossification of the abdominal incision one year after surgery to conclude.